Medicare Enrolled

Dr. Eric Diner, M.D.

Urology Physician · St. Petersburg, FL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
620 10TH STREET N., St. Petersburg, FL 33705
7278247146
In practice since 2006 (19 years)
NPI: 1659473940 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Diner from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Diner? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Diner

Dr. Eric Diner is an urology physician in St. Petersburg, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Diner performed 21,256 Medicare services across 1,711 unique beneficiaries.

Between the years covered by Open Payments, Dr. Diner received a total of $9,016 from 47 pharmaceutical and/or device companies across 258 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Diner is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 5% volume in FL $9,016 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 96738 Clear January 31, 2027
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary

Medicare Utilization ↗
21,256
Medicare services
Top 5% in FL for urology physician
1,711
Unique beneficiaries
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,119 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Testosterone injection
An injection of testosterone cypionate, a form of testosterone hormone. The dose is measured in milligrams.
18,800 $0 $0
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
656 $89 $311
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
582 $60 $221
Bladder ultrasound after voiding
An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder.
172 $8 $25
Leuprolide acetate (for depot suspension), 7.5 mg 139 $136 $338
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
134 $177 $577
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
116 $62 $181
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
102 $115 $409
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
93 $99 $433
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
87 $10 $35
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
62 $42 $162
Bladder instillation of anti-cancer drug
A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue.
32 $68 $213
Limited ultrasound of pelvis
A focused ultrasound exam of the pelvic area to evaluate specific structures. This procedure provides images of the pelvis to assist in medical assessment.
24 $36 $118
Office visit for established patient
An office visit for an existing patient that may not require the healthcare professional to be present.
24 $17 $162
Non-hormonal chemotherapy injection
This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue.
23 $50 $174
Prostate gland biopsy
A procedure to remove small samples of tissue from the prostate gland for laboratory examination.
22 $172 $589
Testosterone undecanoate injection (Aveed)
An injection of testosterone undecanoate, a form of testosterone hormone. This procedure involves administering the medication via injection.
22 $1 $3
Ureteral stent insertion via endoscope
A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder.
21 $101 $438
Ultrasound guidance for needle placement
Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure.
21 $45 $141
Imaging of urinary tract with contrast
An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures.
19 $19 $68
Endoscopic removal of foreign body, stone, or stent from urethra or bladder
A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item.
18 $248 $772
Initial hospital admission, low complexity
Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter.
18 $66 $433
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
17 $138 $435
Ureteral stone crushing with stent insertion
An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open.
16 $338 $1,056
Ureteral stent insertion via cystoscopy
A tube is placed into the ureter using an endoscope inserted through the bladder.
13 $95 $325
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
12 $92 $257
Transurethral prostate removal with electrocautery
This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding.
11 $567 $1,860
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.3% high complexity
90.3% medium
9.4% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$9,016
Total received (2018-2024)
Avg $1,288/year across 7 years
Top 23% in FL for urology physician
47
Companies
258
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,016 (66.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$3,000 (33.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$668
2023
$4,169
2022
$1,009
2021
$790
2020
$918
2019
$945
2018
$518

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Intuitive Surgical, Inc.
$3,000
Coloplast Corp
$1,231
Astellas Pharma US Inc
$902
Endo Pharmaceuticals Inc.
$476
Sumitomo Pharma America, Inc.
$326
Boston Scientific Corporation
$256
AbbVie Inc.
$237
Axonics, Inc.
$202
ABBVIE INC.
$195
Janssen Biotech, Inc.
$188
COLOPLAST CORP
$182
AbbVie, Inc.
$158
Antares Pharma, Inc.
$143
PROCEPT BioRobotics Corporation
$141
PFIZER INC.
$127
Endo USA, Inc.
$96
UROVANT SCIENCES INC
$95
C. R. Bard, Inc. & Subsidiaries
$80
Acerus Pharmaceuticals Corporation
$69
Myovant Sciences Inc.
$69
Allergan Inc.
$63
Avadel Specialty Pharmaceuticals, LLC
$61
Valencia Technologies Corporation
$60
TOLMAR Pharmaceuticals, Inc.
$56
Laborie Medical Technologies Corp.
$50
Progenics Pharmaceuticals, Inc.
$45
Rochester Medical Corporation
$43
Osiris Therapeutics Inc.
$42
Tolmar, Inc.
$39
Supernus Pharmaceuticals, Inc.
$38
Hollister Incorporated
$30
Ambu Inc.
$30
UroGen Pharma, Inc.
$30
Novartis Pharmaceuticals Corporation
$27
Smith+Nephew, Inc.
$24
NeoTract Inc.
$22
BOSTON SCIENTIFIC CORPORATION
$22
Clarus Therapeutics Inc.
$22
Teleflex LLC
$22
Telix Pharmaceuticals
$18
Myriad Genetic Laboratories, Inc.
$17
Aytu BioScience, Inc
$15
BAXTER HEALTHCARE
$15
Medtronic USA, Inc.
$14
ABC Home Medical Supply, Inc.
$14
Allergan, Inc.
$12
Ferring Pharmaceuticals Inc.
$11
Top 3 companies account for 56.9% of total payments
Associated products mentioned in payments ›
ALTIS · AMS · AQUABEAM ROBOTIC SYSTEM · AVEED · Androgel · Axonics · BOTOX · BOTOX THERAPEUTIC · BRACAnalysis CDx · Bard Urinary Drainage Bag · Bulkamid · DAVINCI XI · ELIGARD · ERLEADA · GEMTESA · GENERAL - PELVIC ORGAN PROLAPSE · GENERAL BPH · GRAFIX PL · GRAFIX/GRAFIXPL/STRAVIX · ILLUCCIX · INTERSTIM · JATENZO · JELMYTO · LUPRON DEPOT · LithoVue · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · NOCDURNA · Natesto · Noctiva · ORGOVYX · OTREXUP · Otrexup · PLUVICTO · PYLARIFY · RESTORELLE · REZUM · ReTrace · SOLESTA · SPEEDICATH · SpaceOAR VUE System - 10mL · SpeediCath · TISSEEL · TITAN · TLANDO · TOVIAZ · Titan · UroLift · VaPro · WATCHMAN · XIAFLEX · XTANDI · XYOSTED · Xtandi · eCoin Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (67%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $42 per 100 Medicare services performed
Looking for an urology physician in St. Petersburg?
Compare urology physicians in the St. Petersburg area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians within 10 mi
111
Per 100K population
11.6
County median income
$70,293
Nearest hospital
ST ANTHONYS HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Diner is a mixed practice specialist, with above-average Medicare volume (top 5% in FL), with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Diner experienced with testosterone injection?
Based on Medicare claims data, Dr. Diner performed 18,800 testosterone injection services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Diner receive payments from pharmaceutical companies?
Yes. Dr. Diner received a total of $9,016 from 47 companies across 258 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Diner's costs compare to other urology physicians in St. Petersburg?
Dr. Diner's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Diner) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →